INBP OTC
Integrated BioPharma, Inc.
1W: -4.2%
1M: +1.1%
3M: +1.1%
YTD: -50.8%
1Y: -37.2%
3Y: -45.4%
5Y: -84.3%
$0.18
+0.02 (+12.50%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$44M
-19.3% ▼
5Y CAGR: -7.1%
Gross Profit
$800K
-85.6% ▼
5Y CAGR: -39.0%
Operating Income
-$3M
-233.9% ▼
Net Income
-$3M
-451.7% ▼
EPS (Diluted)
$-0.09
-453.3% ▼
EBITDA
-$1M
-139.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $56M | $51M | $50M | $54M | $44M |
| YoY Growth | -11.5% | -9.9% | -0.7% | +8.0% | -19.3% |
| Cost of Revenue | $50M | $47M | $46M | $49M | $43M |
| Gross Profit | $7M | $4M | $4M | $6M | $800K |
| Gross Margin | 11.6% | 8.0% | 7.7% | 10.2% | 1.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4M | $4M | $4M | $4M | $4M |
| Operating Expenses | $4M | $4M | $4M | $4M | $4M |
| Operating Income | $2M | $120K | $251K | $2M | -$3M |
| Operating Margin | 3.5% | 0.2% | 0.5% | 3.7% | -6.2% |
| Interest Expense | $128K | $40K | $52K | $46K | $12K |
| Income Before Tax | $3M | $100K | $268K | $2M | -$3M |
| Tax Expense | -$1M | $134K | $156K | $1M | $279K |
| Net Income | $4M | -$34K | $112K | $808K | -$3M |
| Net Margin | 6.8% | -0.1% | 0.2% | 1.5% | -6.5% |
| EPS (Diluted) | $0.12 | $-0.00 | $0.00 | $0.03 | $-0.09 |
| EBITDA | $4M | $1M | $1M | $3M | -$1M |
| Shares Outstanding | 32M | 30M | 31M | 31M | 31M |